p.67 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

Circulation. 2025;151:e771–e862. DOI: 10.1161/CIR.0000000000001309 April 1, 2025 e837

infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Am Heart J. 2013;165:50–56. 4.	 Lipinski MJ, Baker NC, Escarcega RO, et al. Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis. Am Heart J. 2015;169:6–16.e16. 5.	 Anand A, Lee KK, Chapman AR, et al. High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial. Circulation. 2021;143:2214–2224. 6.	 Shah ASV, Anand A, Strachan FE, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a steppedwedge, cluster-randomised controlled trial. Lancet. 2018;392:919–928. 7.	 Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858–867. 8.	 Chew DP, Lambrakis K, Blyth A, et al. A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT). Circulation. 2019;140:1543–1556. 9.	 Neumann JT, Sorensen NA, Rubsamen N, et al. Evaluation of a new ultrasensitivity troponin I assay in patients with suspected myocardial infarction. Int J Cardiol. 2019;283:35–40. 10.	 Boeddinghaus J, Nestelberger T, Twerenbold R, et al. Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using highsensitivity cardiac troponin I. Circulation. 2017;135:1597–1611. 11.	 Twerenbold R, Costabel JP, Nestelberger T, et al. Outcome of applying the ESC 0/1-hour algorithm in patients with suspected myocardial infarction. J Am Coll Cardiol. 2019;74:483–494. 12.	 Badertscher P, Boeddinghaus J, Twerenbold R, et al. Direct comparison of the 0/1h and 0/3h algorithms for early rule-out of acute myocardial infarction. Circulation. 2018;137:2536–2538. 13.	 Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/ SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368–e454. 14.	 National Center for Health Statistics. Emergency Department Visits in the United States, 2016-2021. Accessed August 6, 2023. https://www.cdc. gov/nchs/dhcs/ed-visits/index.htm. 15.	 Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237–269. 16.	 Mahler SA, Riley RF, Hiestand BC, et al. The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes. 2015;8:195–203. 17.	 Than MP, Pickering JW, Aldous SJ, et al. Effectiveness of EDACS versus ADAPT accelerated diagnostic pathways for chest pain: a pragmatic randomized controlled trial embedded within practice. Ann Emerg Med. 2016;68:93–102.e101. 18.	 Twerenbold R, Neumann JT, Sorensen NA, et al. Prospective validation of the 0/1-h Algorithm for early diagnosis of myocardial infarction. J Am Coll Cardiol. 2018;72:620–632. 19.	 Mark DG, Huang J, Chettipally U, et al. Performance of coronary risk scores among patients with chest pain in the emergency department. J Am Coll Cardiol. 2018;71:606–616. 20.	 Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998–1006. 21.	 Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–e651. 22.	 Lopez-Sendon J, Coma-Canella I, Alcasena S, et al. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3. J Am Coll Cardiol. 1985;6:1273–1279. 23.	 Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation. 2007;116:e95–e98. 24.	 Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115:e356–e375. 25.	 Cullen L, Mueller C, Parsonage WA, et al. Validation of high-sensitivity tro-

ponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emer- gency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62:1242–1249. 26.	 Twerenbold R, Badertscher P, Boeddinghaus J, et al. Effect of the FDA

regulatory approach on the 0/1-h algorithm for rapid diagnosis of MI. J Am Coll Cardiol. 2017;70:1532–1534. 27.	 Chiang CH, Chiang CH, Lee GH, et al. Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis. Heart. 2020;106:985–991. 28.	 Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172:1211–1218. 29.	 Allen BR, Christenson RH, Cohen SA, et al. Diagnostic performance of highsensitivity cardiac troponin T strategies and clinical variables in a multisite US cohort. Circulation. 2021;143:1659–1672. 30.	 Karady J, Morrow DA. Critical appraisal of the negative predictive performance of the European Society of Cardiology 0/1-hour algorithm for evaluating patients with chest pain in the US. JAMA Cardiol. 2023;8:314–316. 31.	 Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868–877. 32.	 Sandoval Y, Apple FS, Mahler SA, et al. High-sensitivity cardiac troponin

and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of acute chest pain. Circulation. 2022;146:569–581. 3.1.3. Risk Stratification Tools for Patients With STEMI and NSTE-ACS 1.	 Brilakis ES, Wright RS, Kopecky SL, et al. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003;146:811–818. 2.	 Backus BE, Six AJ, Kelder JH, et al. Risk scores for patients with chest pain: evaluation in the emergency department. Curr Cardiol Rev. 2011;7:2–8. 3.	 Gale CP, Manda SO, Weston CF, et al. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart. 2009;95:221–227. 4.	 Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842. 5.	 Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031–2037. 6.	 Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333:1091. 7.	 Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. 8.	 Chew DP, Junbo G, Parsonage W, et al. Perceived risk of ischemic and bleeding events in acute coronary syndromes. Circ Cardiovasc Qual Outcomes. 2013;6:299–308. 9.	 Chew DP, Hyun K, Morton E, et al. Objective risk assessment vs standard care for acute coronary syndromes: a randomized clinical trial. JAMA Cardiol. 2021;6:304–313. 10.	 Gale CP, Stocken DD, Aktaa S, et al. Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial. BMJ. 2023;381:e073843. 11.	 Killip TIII, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457– 464. 12.	 Araujo GN, Silveira AD, Scolari FL, et al. Admission bedside lung ultrasound reclassifies mortality prediction in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2020;13:e010269. 13.	 Lindner M, Lindsey A, Bain PA, et al. Prevalence and prognostic importance of lung ultrasound findings in acute coronary syndrome: a systematic review. Echocardiography. 2021;38:2069–2076. 14.	 van Diepen S, Chen AY, Wang TY, et al. Influence of heart failure symp-

toms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction. Am Heart J. 2014;167:267–273.e261.

Downloaded from http://ahajournals.org by on October 7, 2026